decisionhealth Newsletters, Part B News - 2007 Issue 9 (September)
Infusions raise HHS eyebrows
Subscribe or sign in to view the full article.
Article Overview
This article covers federal concern over unusual infusion therapy billing activity, including how Medicare claims patterns in several cities drew attention from HHS, DOJ, and CMS. It is relevant to billing staff, compliance teams, auditors, and infusion therapy providers who want a general understanding of the enforcement and program integrity context described in the piece.
Why This Topic Matters
The article highlights why infusion therapy billing can attract federal review and how enforcement actions may affect provider enrollment and billing operations.
Article Sections
-
Billing patterns and claim volume in infusion therapy
Discusses unusually large claim volumes reported in selected metropolitan areas and the general drug and therapy context involved.
-
Federal enforcement response and investigation
Summarizes the involvement of federal agencies and the creation of a fraud-focused initiative tied to real-time billing review.
-
Fraud allegations and provider impact
Describes alleged fraudulent claims activity, provider participation, and the resulting scrutiny and enrollment actions affecting the region.
What You Will Learn
- How unusual billing activity can draw attention from federal agencies
- Which organizations are described as responding to suspected fraud
- What kinds of compliance actions may follow scrutiny of infusion therapy providers
- How provider participation in billing schemes can affect regional oversight
Who Should Read This
- Medical coders
- Billing staff
- Compliance officers
- Practice administrators
- Infusion therapy providers
- Healthcare auditors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com